As recently suggested, the role of CD79 mutations in DLBCL may be to block the LYN-mediated induction of anergy [89], providing an additional explanation of why these mutations are frequently selected in ABC DLBCL. The gene discussed is LYN; the disease is diffuse large B-cell lymphoma.